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INTRODUCTION 
 
Polymorphisms within Beta2-adrenergic receptor 
(β2AR) gene have been repeatedly linked to 
hypertension (Ranade et al., 2001, Kazuk et al., 2005).  
 
Among the β2AR polymorphisms detected, Arg16Gly 
and Gln27Glu codons were considered the two most 
important variations.  Arg16Gly especially, has been 
found to be significantly associated with hypertension 
in Caucasian and African subjects (Hong xie. et al., 1999, 
Gerfried et al., 1999). 
 
The amino acid substitution at these codons may lead 
to abnormal regulation of β2AR activity (Garovic et al., 
2002). 
 
The estimated frequencies of variant alleles Gly16 and 
Glu27 in Malaysian subject were 47% and 6.8% 
respectively ( Nik Nor Izah., 2009). 
 
 
 
 
 
 
The aim of the present study was to assess the 
association between β2AR polymorphisms and 
hypertension in our population.  
  
 
 
OBJECTIVE 
 
METHODS 
There were no significant evidence of association in allelic 
and genotypes distribution of Arg16Gly and Glu27Gln 
with elevated blood pressure and hypertension (Table 1). 
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RESULTS 
CONCLUSION 
 
 
 These findings suggest that the variation within codon 16 
and 17 of β2AR gene were unlikely to confer genetic 
susceptibility for hypertension in our population samples. 
 
 The negative association in our study was corresponded to 
that reported in other Asian populations (Jia et al., 2000., 
Norihiro et al., 2001). 
Figure 2. 
SNPs Genotype MAF Allele OR (%95 CI) p value 
Gly16Arg 
Case 
Control 
GG/GA/AA 
14/23/13 
17/22/11 
 
0.490 
0.440 
 
0.817 (0.468-1.426) 
 
0.78 
Gln27Glu 
Case 
control 
CC/CG/GG 
1/5/44 
1/10/39 
 
0.070 
0.120 
 
1.811 (0.682-4.811) 
 
0.37 
Figure 1 
 
PCR-RFLP assay result for selected markers 
in β2AR gene.  A: codon16 PCR product. B: 
lane 1, Arg16Arg; lane 2, Gly16Gly; lane 3, 
Arg16/Gly16. C: codon27 PCR product. D:  
lane 1, Glu27Glu; lane 2, Gln2Gln; lane 3, 
Glu27Gln27.  
To validate the PCR-RFLP 
genotype at codons 16 and 
27, four randomly chosen 
samples were subjected to 
automated direct nucleotide 
sequencing. The results show 
concordance findings with 
PCR-RFLP 
 
Figure 2  
 
Direct nucleotide sequencing of selected sample.  A: Homozygous wild type (Arg16).  B: 
Homozygous TAG to TGG transition resulting change of Arginine to Glycine at codon 16 
(Gly16). C: Homozygous Glu27. D: Heterozygous TTG to TTC transition resulting in possible 
Glutamine to Glutamic acid at codon 27 (Gln27Glu). 
 
Figure 1. 
Table  1. 
100 subjects were included in this study. Hypertensive 
patient samples were recruited from governmental 
clinics in Kuantan-Pahang. 
 
5ml of blood was taken from patients. The sample 
was subjected to DNA extraction by  using Magtration 
system . 
 
Quantity and quality of DNA was measured by using 
biophotometer plus device. 
 
Genotyping was done using polymerase chain 
reaction (PCR) based on restriction fragment length 
polymorphism (RFLP) assay. 
 
The two SNPs at codon 16 & 27 was genotyped by 
amplifying 107 and 353 base pair by hot start Master 
Mix in 20μl reaction volume . 
 
 
 
